Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Chronic Heart Failure

  Free Subscription


1 Am Heart J
3 Circ Arrhythm Electrophysiol
4 Circ Heart Fail
1 Circ Res
2 Circulation
1 Eur J Heart Fail
1 Hypertension
4 Int J Cardiol
1 J Am Coll Cardiol
4 J Card Fail
1 J Cardiovasc Pharmacol
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am Heart J

  1. LINDENFELD J, Abraham WT, Maisel A, Zile M, et al
    Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF).
    Am Heart J. 2019;214:18-27.
    PubMed     Text format    

    Circ Arrhythm Electrophysiol

  2. LIANG JJ, Santangeli P
    Medical Versus Implanted Device Therapy for Patients With Heart Failure With Reduced Ejection Fraction.
    Circ Arrhythm Electrophysiol. 2019;12:e007455.
    PubMed     Text format    

  3. TSENG AS, Kunze KL, Lee JZ, Amin M, et al
    Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction.
    Circ Arrhythm Electrophysiol. 2019;12:e006951.
    PubMed     Text format     Abstract available

    Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator.
    Circ Arrhythm Electrophysiol. 2019;12:e007430.
    PubMed     Text format    

    Circ Heart Fail

  5. GRIFFIN JM, Maurer MS
    Cardiac Amyloidosis A Rare Disease in Older Adults Hospitalized for Heart Failure?
    Circ Heart Fail. 2019;12:e006169.
    PubMed     Text format    

  6. RAO VS, Ahmad T, Brisco-Bacik MA, Bonventre JV, et al
    Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function.
    Circ Heart Fail. 2019;12:e005552.
    PubMed     Text format     Abstract available

  7. BUTLER J, Zannad F, Fitchett D, Zinman B, et al
    Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart Failure.
    Circ Heart Fail. 2019;12:e005875.
    PubMed     Text format     Abstract available

  8. GILSTRAP LG, Dominici F, Wang Y, El-Sady MS, et al
    Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States.
    Circ Heart Fail. 2019;12:e005407.
    PubMed     Text format     Abstract available

    Circ Res

  9. Correction to: Role of SIRT1 in Modulating Acetylation of the Sarco- Endoplasmic Reticulum Ca(2+)-ATPase in Heart Failure.
    Circ Res. 2019;124:e149.
    PubMed     Text format    


  10. DUNLAY SM, Givertz MM, Aguilar D, Allen LA, et al
    Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.
    Circulation. 2019 Jun 6:CIR0000000000000691. doi: 10.1161/CIR.0000000000000691.
    PubMed     Text format     Abstract available

  11. BRANCH KR, Probstfield JL, Eikelboom JW, Bosch J, et al
    Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.039609.
    PubMed     Text format     Abstract available

    Eur J Heart Fail

  12. FELKER GM, Borentain M, Cleland JG, DeSouza MM, et al
    Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure.
    Eur J Heart Fail. 2019 Jun 6. doi: 10.1002/ejhf.1504.
    PubMed     Text format     Abstract available


  13. YU Y, Cao Y, Bell B, Chen X, et al
    Brain TACE (Tumor Necrosis Factor-alpha-Converting Enzyme) Contributes to Sympathetic Excitation in Heart Failure Rats.
    Hypertension. 2019 Jun 3:HYPERTENSIONAHA11912651.
    PubMed     Text format     Abstract available

    Int J Cardiol

  14. SUN LY, Kimmoun A, Takagi K, Liu PP, et al
    Ethnic differences in acute heart failure outcomes in Ontario.
    Int J Cardiol. 2019 May 22. pii: S0167-5273(19)32001.
    PubMed     Text format     Abstract available

  15. GENG Q, Li S, Wang Z, Ren Y, et al
    Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2019 May 23. pii: S0167-5273(19)31213.
    PubMed     Text format     Abstract available

  16. SCHAFER A, Werner N, Westenfeld R, Moller JE, et al
    Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock - A European experienced users working group opinion.
    Int J Cardiol. 2019 May 21. pii: S0167-5273(19)31855.
    PubMed     Text format     Abstract available

  17. LUPON J, Cediel G, Moliner P, de Antonio M, et al
    A bio-clinical approach for prediction of sudden cardiac death in outpatients with heart failure: The ST2-SCD score.
    Int J Cardiol. 2019 May 23. pii: S0167-5273(19)31056.
    PubMed     Text format     Abstract available

    J Am Coll Cardiol

  18. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    PubMed     Text format    

    J Card Fail

  19. ROWIN EJ, Romashko M, Testani JM, Koethe BC, et al
    Chronic Heart Failure is Infrequently Associated with Renal Dysfunction in Hypertrophic Cardiomyopathy.
    J Card Fail. 2019 May 31. pii: S1071-9164(19)30318.
    PubMed     Text format    

  20. MARWICK TH, Huynh Q
    Risk Prediction in Heart Failure: Untranslatable or Lost in Translation?
    J Card Fail. 2019 May 31. pii: S1071-9164(19)30587.
    PubMed     Text format    

  21. WARRAICH HJ, O'Connor CM, Yang H, Granger BB, et al
    African Americans with Advanced Heart Failure are More Likely to Die in a Healthcare Facility than Home or Hospice: An Analysis from the PAL-HF Trial.
    J Card Fail. 2019 May 31. pii: S1071-9164(19)30345.
    PubMed     Text format    

  22. SEIF E, Sherazi S, Bravo-Jaimes K, Gosev I, et al
    Corrigendum to "Driving Pulseless: A driving survey of patients with LVADs and their providers" Journal of Cardiac Failure Vol. 25 No. 9, pp. 220-221.
    J Card Fail. 2019 May 31. pii: S1071-9164(19)30475.
    PubMed     Text format    

    J Cardiovasc Pharmacol

  23. TOYODA S, Arikawa T, Inami S, Nishikawa R, et al
    Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
    J Cardiovasc Pharmacol. 2019;73:365-372.
    PubMed     Text format     Abstract available

    PLoS One

  24. SHAMALI M, Konradsen H, Stas L, Ostergaard B, et al
    Dyadic effects of perceived social support on family health and family functioning in patients with heart failure and their nearest relatives: Using the Actor-Partner Interdependence Mediation Model.
    PLoS One. 2019;14:e0217970.
    PubMed     Text format     Abstract available

  25. ZOPPINI G, Bergamini C, Mantovani A, Dauriz M, et al
    The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.
    PLoS One. 2018;13:e0209794.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.